A recent study suggest that individuals with FLG‐null mutations exhibit increased LC maturation markers in nonlesional skin, regardless of AD presence, linking FLG‐null mutations to enhanced LC maturity.101. The gene discussed is FLG; the disease is Alzheimer disease.